Intervention

Placebo control

ClinicalTrials.gov intervention label

Clinical trials19
Recruiting0
Common conditions25
Lead sponsors shown15

Clinical trials

19 shown
Gut Microbiome Changes During Abemaciclib Therapy in Breast CancerNCT07406594 · 2027-10-01
NOT_YET_RECRUITING
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPDNCT07658339 · 2026-07-11
NOT_YET_RECRUITING
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight IndividualsNCT07336615 · 2025-10-09
COMPLETED
Taurine Supplementation Associated or Not With Exercise: Effect on Browning of White Adipose Tissue in Elderly Women With Sarcopenic ObesityNCT05415176 · 2023-02-27
UNKNOWN
Supplementation of YMETA, on Gut Health, Immunity and Metabolism in Pre-diabetic Adult PopulationNCT05400525 · 2022-06-15
COMPLETED
Green Tea Supplementation, Fat Oxidation and Body Composition in Overweight IndividualsNCT04628624 · 2018-12-01
COMPLETED
The Effect of Decaffeinated Green Tea Polyphenol Intake on the Risk of Precocious Puberty Among Obese GirlsNCT03628937 · 2018-08-28
UNKNOWN
Hypoglycemic Efficacy of Greenyn Momordica Charantia Extracts in Diabetic SubjectsNCT03151837 · 2017-05-10
COMPLETED
Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for InjectionNCT04164615 · 2016-11-24
UNKNOWN
Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in FemalesNCT02922725 · 2016-11-01
TERMINATED
A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese SubjectsNCT02692781 · 2016-02-01
COMPLETED
Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)NCT01672255 · 2012-10-01
COMPLETED
Effects of IGF-I in HIV Metabolic DiseaseNCT01329744 · 2011-06-01
TERMINATED
Oral CF101 Tablets Treatment in Patients With Rheumatoid ArthritisNCT01034306 · 2010-10-01
COMPLETED
The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic PatientsNCT00758927 · 2009-07-01
UNKNOWN
The Effect of Natural Food Flavourings on Gastrointestinal and Cardiovascular Physiological Responses.NCT01350284 · 2009-06-01
COMPLETED
A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese PatientsNCT00675987 · 2007-05-01
COMPLETED
Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes MellitusNCT00545857 · 2002-06-01
COMPLETED
Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk PregnanciesNCT01355822 · 2002-04-01
COMPLETED

Common conditions

Diabetes Mellitus, Type 22Obesity2Breast Cancer1Browning of Subcutaneous White Adipose Tissue Post Intervention1COPD (Chronic Obstructive Pulmonary Disease)1Diabetes Mellitus1Fat Burn1Gastric Emptying1Gastrointestinal1HER-2 Positive Breast Cancer1HER-2-positive Advanced Breast Cancer1High Risk Pregnancy1HIV Lipodystrophy1Hypercholesterolemia1Hyperglycemia1Hypertension1Hypertriglyceridemia1Hypoglycemia Associated Autonomic Failure1Major Depressive Disorder1Metabolic and Inflammatory Variables Post Intervention1Overweight , Obesity1Overweight and Obesity1Pediatric Obesity1Pre-diabetes1Puberty, Precocious1

Trial status mix

COMPLETED11
UNKNOWN4
NOT_YET_RECRUITING2
TERMINATED2

Phase mix

NA8
PHASE14
PHASE43
PHASE22
PHASE32
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.